Literature DB >> 15910222

Formation of A2143G mutation of 23S rRNA in progression of clarithromycin resistance in Helicobacter pylori 26695.

Jing Shen1, Jian-Zhong Zhang, Yang Ke, Dajun Deng.   

Abstract

The aim of this work was to investigate the link between 23S rRNA mutation and clarithromycin (CLR)-resistant Helicobacter pylori (H. pylori). CLR-resistant (CLRr) H. pylori strains were selected from the parent strain, H. pylori 26695, using medium containing CLR. Point mutations of 23S rRNA were analyzed by denaturing high-performance liquid chromatography and sequencing and restriction fragment length polymorphism (RFLP). Protein profiles of these strains were obtained by surface-enhanced laser/desorption ionization time-of-flight mass spectrometry technology. Two phenotype-stable L-CLRr resistant strains (MIC 8, 10 microg/ml) and two subsequent CLRr strains (MIC 32 microg/ml) were obtained. An A2143G mutation of 23S rRNA was detectable in two CLRr strains, but in neither the CLRs parent strain nor the L-CLRr strains. Four clinical CLRr H. pylori strains were obtained from 41 Chinese H. pylori isolates. The A2143G mutation was observed in all four CLRr isolates, but not in the six analyzed CLRs ones. Protein profiling showed that the pattern of protein expression was changed from the CLRs parent strain to the L-CLRr strains and then to the CLRr strains progressively. The formation of A2143G mutations of 23S rRNA might be a late event in the development of CLR-resistance of H. pylori 26695. Early events related to alteration of the pattern of protein expression might be involved in the development of CLR-resistance too.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15910222     DOI: 10.1089/mdr.2005.11.100

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  4 in total

1.  Occurrence of Mutations in the Antimicrobial Target Genes Related to Levofloxacin, Clarithromycin, and Amoxicillin Resistance in Helicobacter pylori Isolates from Buenos Aires City.

Authors:  Gerardo Zerbetto De Palma; Nicolas Mendiondo; Andrés Wonaga; Luis Viola; Daniela Ibarra; Esteban Campitelli; Nicolas Salim; Rodolfo Corti; Cinthia Goldman; Mariana Catalano
Journal:  Microb Drug Resist       Date:  2016-07-08       Impact factor: 3.431

2.  Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of Helicobacter pylori.

Authors:  Xiao-Feng Luo; Jian-Hua Jiao; Wen-Yue Zhang; Han-Ming Pu; Bao-Jin Qu; Bing-Ya Yang; Min Hou; Min-Jun Ji
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

3.  Prevalence of A2143G mutation of H. pylori-23S rRNA in Chinese subjects with and without clarithromycin use history.

Authors:  Zhuoqi Liu; Jing Shen; Lian Zhang; Lin Shen; Qiang Li; Baozhen Zhang; Jing Zhou; Liankun Gu; Guoshuang Feng; Junling Ma; Wei-Cheng You; Dajun Deng
Journal:  BMC Microbiol       Date:  2008-05-28       Impact factor: 3.605

4.  Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori.

Authors:  Zi-Han Feng; Ling Fan; Jing Yang; Xing-Yue Huo; Yan Guo; Yi Zhang; Chun-Hui Lan
Journal:  BMC Microbiol       Date:  2019-08-05       Impact factor: 3.605

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.